Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
EZH2 INHIBITION THERAPIES FOR THE TREATMENT OF ANDROGEN RECEPTOR MUTATED PROSTATE CANCERS

No-Receipt date 2025-01135 - 31/03/2025
No-Filing date 20250400678 - 31/03/2025
No-Granting date 3117922 - 07/04/2025
No-EPO application date 21827282.1 - 18/11/2021
No-EPO granting date 4247371 - 01/01/2025
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 4/2025 - 14/05/2025
Expiration date 19/11/2041
Kind of title Validation of European Patent
Legal status VALID
Priorities US202063115165 P18/11/2020/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/4166
A61K 31/4433
A61K 45/06
A61P 35/00
A61P 35/04

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1718211 CONSTELLATION PHARMACEUTICALS, INC. 470 ATLANTIC AVENUE, SUITE 1401BOSTON, MA 02210 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
4504736 BRADLEY, WILLIAM, D.
4504737 CUI, JIKE
4504738 SUN, KAIMING
4504739 TROJER, PATRICK
4504740 WANG, JING
4504741 WU, RENTIAN

Representatives
CodeFirstnameSurnameAddressTownZip
3614AIKATERINISIOTOU "KATERINA SIOTOU KAI SYNERGATES DIKIGORIKI ETAIREIA"PATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History

Title Instruments

Payments history 4 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015